A revolutionary test known as the fecal immunochemical test (FIT) has demonstrated unprecedented success in reducing colorectal cancer mortality rates, offering a more accessible and effective ...
PLEASANTON, Calif., Jan. 3, 2025 /PRNewswire/ -- DiaCarta Inc., a precision molecular diagnostic company, has announced the publication of its prospective clinical trial data on its blood-based ...